AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress |

0
146


— Fifteen abstracts underscore AbbVie’s commitment to people living with migraine

— AbbVie to present late-breaking data from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) study on neck pain with headache in people with and without migraine





Source link